COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon
Peter Libby, MD, a cardiovascular medicine specialist, Brigham and Women’s Hospital, and Mallinckrodt Professor of Medicine, Harvard Medical School, explains his research into COVID and how damages the endothelium on blood vessels. #AHA #AHA22 #SARSCoV2 #Coronavirus #COVID

VIDEO: Why does COVID-19 damage vascular beds?

Peter Libby, MD, a cardiovascular medicine specialist at Brigham and Women’s Hospital, explains his research into COVID-19 and how it damages the endothelium of blood vessels. 

COVID-19’s impact on cardiovascular health mostly felt in the first 30 days

The new study, published in PLOS ONE, included registry data from nearly 4,500 patients. While COVID-19 patients faced a heightened risk of adverse cardiovascular outcomes early on, many of those risks faded after approximately one month. 

How cardiologists can fight back against misinformation

Edward T.A. Fry, MD, president of the American College of Cardiology and a veteran cardiologist, shared his perspective on the many ways cardiologists can work to limit medical misinformation and disinformation. 

Cardiovascular disease still the No. 1 cause of death in the world

A new global report, based on data from 204 different countries and territories, has been published in full in the Journal of the American College of Cardiology.

COVID-19 infection and vaccination linked to debilitating heart condition—risk from vaccines ‘relatively slim’

Postural orthostatic tachycardia syndrome is a significant, but treatable condition. The risk among COVID-19 patients was considerably higher than the risk after vaccination, researchers explained. 

doctor telehealth computer screen

Telehealth for cardiovascular disease patients: 3 key benefits and 5 ongoing challenges

Telehealth can provide significant value when it comes to managing and monitoring patients with CVD or suspected CVD. A new scientific statement from the American Heart Association explores the latest details on this evolving treatment option. 

Former U.S. Surgeon General Jerome Adams (2017-2021) spoke at the opening session of the American Heart Association (AHA) 2022 Scientific Sessions last week and said cardiologists need to help end the COVID pandemic and tackle the even bigger epidemic of hypertension. He highlighted hypertension and called it a clear public health emergency, causing more than 670,000 U.S. deaths per year. #AHA22 #hypertension

Former surgeon general says cardiologists need to address hypertension and remaining COVID cases

Former U.S. Surgeon General Jerome Adams spoke at the AHA 2022 Scientific Sessions and asked cardiologists to help end the COVID pandemic and tackle the even bigger epidemic of hypertension.

Image from the American Heart Association (AHA) annual scientific sessions where a large amount of late-breaking cardiology science is presented. #AHA #AHA22 #AHA2022

Links to the American Heart Association 2022 late-breaking studies

The American Heart Association 2022 Scientific Sessions included 35 late-breaking studies and 39 featured science sessions presented at the meeting in Chicago, Nov. 5-7. Here is the list of all these studies with links to more information on the data.

Displaying 33 - 40 of 430

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.